Skip to main content
. 2014 Jul 26;6(3):278–287. doi: 10.4252/wjsc.v6.i3.278

Figure 2.

Figure 2

Bone marrow-derived mesenchymal stem cell cell-sheet implantation or bone marrow-derived mesenchymal stem cell IV-administration attenuates aortic aneurysm progression and expansion. Aortic diameter was measured at the infrarenal aorta in the bone marrow-derived mesenchymal stem cell (BM-MSC) cell-sheet (A) or the BM-MSC IV-administration. Data are assessed by one-way ANOVA with Bonferroni correction. aP < 0.05 vs apoE-/- group, cP < 0.05 vs apoE-/- + ATII group. Data are from Hashizume et al[51] and Fu et al[53]. ATII: Angiotensin II; iv: Intravenous.